Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "equity"

432 News Found

Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure
Hospitals | April 15, 2026

Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure

Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform


Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio
Biotech | April 09, 2026

Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio

The acquisition complements Gilead’s existing oncology expertise and development infrastructure


Solara Active Pharma dispatches final rights share call notice; Rs 112.5 per share due by May 7
News | April 08, 2026

Solara Active Pharma dispatches final rights share call notice; Rs 112.5 per share due by May 7

API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle


WHO updates global guidelines to combat opioid crisis
Healthcare | April 08, 2026

WHO updates global guidelines to combat opioid crisis

Opioid dependence remains a major driver of death and disease worldwide


Cupid deposits Rs. 82.88 crore for strategic stake in Baazar Style Retail
News | April 05, 2026

Cupid deposits Rs. 82.88 crore for strategic stake in Baazar Style Retail

The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores


Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies
Biotech | April 04, 2026

Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies

Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy


Strides acquires generic brands from Sandoz to boost Africa business
News | March 19, 2026

Strides acquires generic brands from Sandoz to boost Africa business

The initial consideration for the transaction is US$ 12 million


Jubilant Ingrevia acquires Remidex Pharma for Rs 16.5 crore
News | March 14, 2026

Jubilant Ingrevia acquires Remidex Pharma for Rs 16.5 crore

Remidex manufactures micronutrient premixes and nutraceuticals,


Roche shareholders back full slate of proposals, approve record dividend increase
News | March 11, 2026

Roche shareholders back full slate of proposals, approve record dividend increase

Dr Severin Schwan was re-elected as Chairman of the Board with 97.75% of the votes